Stock BLCO BAUSCH + LOMB CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Bausch + Lomb Corporation

Equities

BLCO

CA0717051076

Real-time Estimate Cboe BZX
Other stock markets
 17:39:59 14/05/2024 BST 		5-day change 1st Jan Change
14.82 USD +0.37% Intraday chart for Bausch + Lomb Corporation -0.87% -13.42%
05-06 Bausch + Lomb Shares Rise After Morgan Stanley Upgrade MT
05-06 Morgan Stanley Upgrades Bausch + Lomb to Overweight From Equalweight, Raises Price Target to $18 From $16 MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bausch + Lomb Shares Rise After Morgan Stanley Upgrade
MT
Morgan Stanley Upgrades Bausch + Lomb to Overweight From Equalweight, Raises Price Target to $18 From $16
MT
Bausch Health Announces First Quarter 2024 Results
AQ
RBC Capital Reviews Bausch + Lomb's Q1 Results
MT
Deutsche Bank Adjusts Bausch + Lomb Price Target to $14 From $18, Maintains Hold Rating
MT
Needham Says Bausch + Lomb's Q1 Showed a "Strong Start" to The Year
MT
Bausch + Lomb Q1 Loss Widens, Revenue Increases
MT
Transcript : Bausch + Lomb Corporation, Q1 2024 Earnings Call, May 01, 2024
Bausch + Lomb Q1 Net Loss Widens, But Revenue Higher; Raises 2024 Revenue Growth Guidance
MT
Bausch + Lomb: Q1 Earnings Snapshot
AQ
Bausch + Lomb Brief: Raising Full-Year 2024 Constant Currency Revenue Growth Guidance
MT
Bausch + Lomb Brief: Q1 Adjusted EBITDA (non-GAAP) of US$180 Million
MT
Bausch + Lomb Brief: Q1 Revenue of US$1.099 Billion; GAAP Net Loss Attributable of $167 Million
MT
Bausch + Lomb Announces First-Quarter 2024 Results
BU
Bausch + Lomb Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting
BU
Bausch + Lomb Says Study Shows Improvements in Dry Eyes With Nutritional Supplement
MT
Bausch + Lomb Reports "Statistically Significant" Results From Study of Nutritional Supplement for Dry Eyes
MT
Bausch + Lomb Brief: Announcing "Statistically Significant" Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes
MT
Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BLCO Stock
  4. News Bausch + Lomb Corporation